skip to main content

Lipid review after statin — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsLipid review after statinGPhC CRA

A man starts atorvastatin 20 mg for primary prevention and asks when response will be reviewed. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: ALipid profile and adherence review after an appropriate interval

This scenario assesses Lipid review after statin in a UK pharmacy practice context. Statin response and adherence are commonly reviewed after initiation or dose adjustment, with safety tests as indicated. The best answer is Lipid profile and adherence review after an appropriate interval because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: NICE CKS; BNF